1,647 results match your criteria: "University of Vermont Medical Center[Affiliation]"
J Antimicrob Chemother
May 2024
Department of Emergency Medicine and Division of Infectious Diseases, Olive View-UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA 91342, USA.
Background: Urinary tract infections (UTIs) are commonly treated in the emergency department (ED), and unfortunately, resistance to first-line agents is increasing.
Objectives: To characterize treatment of pyelonephritis in a nationally representative sample of ED patients and to identify patient- and treatment-specific factors associated with receiving initial inactive antibiotics.
Methods: We conducted a multicentre, observational cohort study utilizing the Emergency Medicine PHARMacotherapy Research NETwork (EMPHARM-NET), comprising 15 geographically diverse US EDs.
Mult Scler
July 2024
Department of Neurological Sciences, Larner College of Medicine, The University of Vermont, Burlington, VT, USA.
J Am Heart Assoc
March 2024
Kiniksa Pharmaceuticals Lexington MA USA.
Background: Rilonacept, a once-weekly interleukin-1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin-1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology and Outcomes Study). The RHAPSODY long-term extension further explored recurrent pericarditis natural history and treatment duration decision-making during 24 additional months of open-label rilonacept treatment.
Methods And Results: Seventy-four patients commenced the long-term extension, with a median (maximum) total rilonacept duration of 22 (35) months.
J Neurosurg Case Lessons
March 2024
1Division of Neurosurgery, University of Vermont Medical Center, Burlington, Vermont; and.
Background: The presence of intracranial collision tumors, histologically distinct tumors occurring in anatomical proximity, is quite rare. Herein, the authors describe the sentinel case of a contiguous collision tumor combination consisting of glioblastoma multiforme and intraventricular subependymoma.
Observations: A 67-year-old male presented with several months of progressive fatigue superimposed on more recently noted word-finding difficulty, slight left-sided weakness, and episodic confusion.
Target Oncol
March 2024
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, 1111 W 17th St., Tulsa, OK, 74107, USA.
Importance: Chemotherapy agents are typically initially tested in their most promising indications; however, following initial US FDA approval, new clinical trials are often initiated in less promising indications where patients experience a worse burden-benefit ratio. The current literature on the burden-benefit profile of lenvatinib in non-FDA-approved indications is lacking.
Objective: This study aimed to evaluate published clinical trials of lenvatinib in order to determine the burden-benefit profile for patients over time.
Trauma Surg Acute Care Open
March 2024
Wright State Physicians, Department of Surgery, Dayton, Ohio, USA.
Objectives: There is little evidence guiding the management of grade I-II traumatic splenic injuries with contrast blush (CB). We aimed to analyze the failure rate of nonoperative management (NOM) of grade I-II splenic injuries with CB in hemodynamically stable patients.
Methods: A multicenter, retrospective cohort study examining all grade I-II splenic injuries with CB was performed at 21 institutions from January 1, 2014, to October 31, 2019.
Arch Pathol Lab Med
November 2024
the Department of Pathology & Laboratory Medicine, Northwell Health, New Hyde Park, New York (Williamson).
Context.—: Autopsies performed on COVID-19 patients have provided critical information about SARS-CoV-2's tropism, mechanisms of tissue injury, and spectrum of disease.
Objective.
Chest
August 2024
Department of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, ON, Canada; Transfusion Medicine Laboratory, Mount Sinai Hospital, Toronto, ON, Canada.
J Clin Rheumatol
March 2024
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Vermont Medical Center and Robert Larner MD College of Medicine at the University of Vermont, Burlington, VT.
J Clin Microbiol
April 2024
International Society for Human and Animal Mycology (ISHAM), Working Group Nomenclature, 's-Hertogenbosch, the Netherlands.
Headache
March 2024
Department of Medicine, University of Vermont, Burlington, Vermont, USA.
Objective: The goal of this study was to clarify whether clinical differences exist between patients with migraine who experience headache that is typically left-sided ("left-migraine") versus right-sided ("right-migraine") during attacks.
Background: Migraine has been associated with unilateral headache for millennia and remains a supportive trait for the clinical diagnosis of migraine of the International Classification of Headache Disorders. It is currently unknown why headache in migraine is commonly unilateral, and whether headache-sidedness is associated with other clinical features.
J Pediatr Surg
June 2024
Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, OH, USA; Department of Anesthesiology, The Ohio State University College of Medicine, Columbus, OH, USA.
Purpose: To perform a single institution review of spinal instead of general anesthesia for pediatric patients undergoing surgical procedures. Spinal success rate, intraoperative complications, and postoperative outcomes including unplanned hospital admission and emergency department visits within seven days are reported.
Methods: Retrospective chart review of pediatric patients who underwent spinal anesthesia for surgical procedures from 2016 until 2022.
J Clin Oncol
May 2024
The Ohio State University, College of Medicine, Columbus, OH.
Nat Commun
February 2024
Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA.
Curr Treat Options Oncol
April 2024
Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.
This paper shines a light on the exciting progress being made in using immunotherapy to treat advanced gastroesophageal cancers. The positive results from trials using drugs like Pembrolizumab and Nivolumab are certainly encouraging and open new possibilities for treating this challenging disease. However, it is clear that we still have a lot to learn about how to predict which patients will benefit most from these treatments.
View Article and Find Full Text PDFJ Pediatr Surg
May 2024
Vermont Oxford Network, Burlington, VT, USA; University of Vermont Larner College of Medicine and University of Vermont Medical Center, Burlington, VT, USA; University of Vermont, Department of Mathematics and Statistics, Burlington, VT, USA. Electronic address:
Background: Limited data exists regarding the mortality of very low birth weight (VLBW) neonates with congenital diaphragmatic hernia (CDH). This study aims to quantify and determine predictors of mortality in VLBW neonates with CDH.
Methods: This analysis of 829 U.
J Cutan Pathol
May 2024
Division of Dermatopathology, University of Vermont Medical Center, Burlington, Vermont, USA.
Storiform collagenoma, also known as sclerotic fibroma, is a relatively rare benign cutaneous tumor consisting of a proliferation of fibroblasts that shows increased production of type I collagen. It may appear as a solitary, sporadic lesion, or, especially when multiple, associated with Cowden syndrome. Giant cell collagenoma has a histopathologic appearance similar to that of storiform collagenoma with the addition of floret-type giant cells.
View Article and Find Full Text PDFInnovations (Phila)
March 2024
Department of Cardiac Surgery, Maine Medical Center, Portland, ME, USA.
Objective: The optimal approach and choice of initial aortic valve replacement (AVR) is evolving in the growing era of transcatheter AVR. Further survival and hemodynamic data are needed to compare the emerging role of rapid deployment (rdAVR) versus stented (sAVR) valve options for AVR.
Methods: The Northern New England Cardiovascular Database was queried for patients undergoing either isolated AVR or AVR + coronary artery bypass grafting (CABG) with rdAVR or sAVR aortic valves between 2015 and 2021.
Trauma Surg Acute Care Open
February 2024
Department of Traumatology, Oslo Universitet Hospital, Oslo, Norway.
Plast Reconstr Surg Glob Open
February 2024
Department of Plastic and Reconstructive Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio.
Background: Wellness programs are especially important in residency. However, the resources available to plastic surgery residents through residency wellness programs have not been described. This study reports current plastic surgery residency wellness programs' organization, leadership, and resources.
View Article and Find Full Text PDFJSES Int
January 2024
Department of Radiology, University of Vermont Medical Center, Burlington, VT, USA.
Background: Native glenoid bone loss presents technical challenges in shoulder arthroplasty. The purpose of this study is to report the mid-term clinical and radiographic outcomes of patients treated with structural humeral head autograft reconstruction of glenoid bone loss in the setting of reverse total shoulder arthroplasty (rTSA).
Methods: Retrospective review of 30 shoulders in 28 patients undergoing rTSA with a structural humeral head autograft to correct glenoid bone loss.
Ann Vasc Surg
May 2024
Division of Vascular Surgery, University of Vermont Medical Center, Burlington, VT. Electronic address:
Background: To analyze surgical site infections (SSIs) after infrainguinal bypass for standard dressings versus closed incision negative pressure wound therapy (ciNPWT) in the Society for Vascular Surgery's Vascular Quality Initiative (VQI).
Methods: We retrospectively analyzed SSI after infrainguinal bypass procedures in the VQI from December 2019 to December 2021 comparing ciNPWT and standard dressings. The primary outcome of any superficial or deep wound infection at 30 days was analyzed in a subset of procedures with 30-day follow-up data (cohort A, n = 1,575).
J Rheumatol
August 2024
D. Ghetie, MD, M. Friedman, MD, Department of Medicine, Division of Rheumatology, Oregon Health & Science University, Portland, Oregon, now with Alpine Immune Sciences, Seattle, Washington, USA.
Objective: Scleritis may be idiopathic or caused by trauma, infections, or an immune-mediated disease (IMD). Our study aimed to understand the relationship between scleritis and IMD, including presenting characteristics, serologies, and treatment course. Understanding these associations may allow clinicians to risk-stratify patients and predict their clinical and treatment course.
View Article and Find Full Text PDFOxf Med Case Reports
January 2024
Department of Medicine, Division of Dermatology, University of Vermont Medical Center, 111 Colchester Avenue, Burlington VT, USA.
J Hosp Med
September 2024
Department of Medicine, Division of Hospital Medicine, The University of Vermont Medical Center, The Robert Larner M.D. College of Medicine at the University of Vermont, Burlington, Vermont, USA.